An observational study in Parkinson Disease, Essential Tremor and Dystonia, sponsored by Washington University School of Medicine. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2019-06-20.
Sponsored by Washington University School of Medicine · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Parkinson Disease by Washington University School of Medicine — 7 open to participants now, 10 under way, none of them phase 3. Parkinson Disease · Washington University School of Medicine.
Among the 32 studies in Parkinson Disease by Washington University School of Medicine, this one has the largest planned enrollment of the 13 observational ones that give a count, is one of 2 that started in 2011, is one of 13 observational ones, and was the 16th registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →7 of the 32 studies in Parkinson Disease by Washington University School of Medicine are open now, in 2 countries. Recruiting first, the newest first:
Washington University School of Medicine · Sites in United States
Ages 50+
Washington University School of Medicine · Sites in United States
Ages 40+ · Healthy volunteers
Washington University School of Medicine · Sites in United States
Ages 50+ · Healthy volunteers
Washington University School of Medicine · Sites in United States
Ages 50+ · Healthy volunteers
Washington University School of Medicine · Sites in United States, Canada
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 1
First in 2004; this study’s year is marked. 2 started in 2011.
This study's planned enrollment of 1,000 is above the median of 96 across 1,088 observational studies indexed under Parkinson Disease.
Median enrollment 31 across the 19 interventional studies, 174 across the 13 observational. Of the 22 that completed or were terminated, 11 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
Washington University School of Medicine is the lead sponsor of 1,806 studies on the registry; 271 are open to participants now.
Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.
1 of the studies in Parkinson Disease by Washington University School of Medicine that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05826457Washington University School of MedicineNorth American Prodromal Synucleinopathy Consortium Stage 2 | 2027-05-01 |
Add it to your calendar (.ics) → With an account.
Among the 32 studies in Parkinson Disease by Washington University School of Medicine, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The object of this study is to longitudinally collect clinical outcomes of patients receiving deep brain stimulation for movement disorders with the objective of making retrospective comparisons and tracking of risks, benefits, and complications.
All patients receiving deep brain stimulation for movement disorders
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Relapsed and refractory
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
High frequency electrical stimulation of deep brain nuclei for the treatment of movement disorders
UPDRS
United Parkinson's Disease Rating Scale (global assessment of motor, non-motor, and quality of life associated with symptoms of Parkinson disease). Total scores range from 0-199. Particular emphasis is paid to subsection 3 (motor), where scores range from 0-56.
Time frame: Change in UPDRS at 1 year after DBS (from preoperative baseline).
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2011 (actual). Primary completion is estimated for Jan 2030, 227 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Washington University School of Medicine →